Clinical Trial Update: Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial comparing conjugated linoleic acid/leucine versus metformin on visceral fat in metabolic syndrome (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Conjugated linoleic acid / leucine
• metformin (metformin)

Snippet

Sponsor: Centro Universitario de Ciencias de la Salud, Mexico | Conditions: Metabolic Syndrome | Phase 2 | Status: COMPLETED